These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

807 related items for PubMed ID: 31619201

  • 1. FGFR3 promotes the growth and malignancy of melanoma by influencing EMT and the phosphorylation of ERK, AKT, and EGFR.
    Li L, Zhang S, Li H, Chou H.
    BMC Cancer; 2019 Oct 16; 19(1):963. PubMed ID: 31619201
    [Abstract] [Full Text] [Related]

  • 2. FUT6 inhibits the proliferation, migration, invasion, and EGF-induced EMT of head and neck squamous cell carcinoma (HNSCC) by regulating EGFR/ERK/STAT signaling pathway.
    Wang Q, Liao C, Tan Z, Li X, Guan X, Li H, Tian Z, Liu J, An J.
    Cancer Gene Ther; 2023 Jan 16; 30(1):182-191. PubMed ID: 36151332
    [Abstract] [Full Text] [Related]

  • 3. PDGF-D/PDGFRβ promotes tongue squamous carcinoma cell (TSCC) progression via activating p38/AKT/ERK/EMT signal pathway.
    Zhang H, Sun JD, Yan LJ, Zhao XP.
    Biochem Biophys Res Commun; 2016 Sep 16; 478(2):845-51. PubMed ID: 27507215
    [Abstract] [Full Text] [Related]

  • 4. CEACAM6 promotes gastric cancer invasion and metastasis by inducing epithelial-mesenchymal transition via PI3K/AKT signaling pathway.
    Zang M, Zhang B, Zhang Y, Li J, Su L, Zhu Z, Gu Q, Liu B, Yan M.
    PLoS One; 2014 Sep 16; 9(11):e112908. PubMed ID: 25398131
    [Abstract] [Full Text] [Related]

  • 5. DDR2 Induces Gastric Cancer Cell Activities via Activating mTORC2 Signaling and Is Associated with Clinicopathological Characteristics of Gastric Cancer.
    Wang YG, Xu L, Jia RR, Wu Q, Wang T, Wei J, Ma JL, Shi M, Li ZS.
    Dig Dis Sci; 2016 Aug 16; 61(8):2272-2283. PubMed ID: 27010547
    [Abstract] [Full Text] [Related]

  • 6. The involvement of FBP1 in prostate cancer cell epithelial mesenchymal transition, invasion and metastasis by regulating the MAPK signaling pathway.
    Zhang YP, Liu KL, Yang Z, Lu BS, Qi JC, Han ZW, Yin YW, Zhang M, Chen DM, Wang XW, Li W, Xin H.
    Cell Cycle; 2019 Oct 16; 18(19):2432-2446. PubMed ID: 31448674
    [Abstract] [Full Text] [Related]

  • 7. MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer.
    Ma K, Fan Y, Dong X, Dong D, Guo Y, Wei X, Ning J, Geng Q, Wang C, Hu Y, Li M, Niu W, Li E, Wu Y.
    Oncotarget; 2017 Jun 13; 8(24):38825-38840. PubMed ID: 28418915
    [Abstract] [Full Text] [Related]

  • 8. NEFL promotes invasion and migration of esophageal squamous carcinoma cells via the EGFR/AKT/S6 pathway.
    Fan ZL, Yang LY, Zhang N, Feng D, Guo J, Chang C, Yuan Q, Cai Y, Zhang Y, Wei WQ, Wang MR, Hao JJ.
    Yi Chuan; 2022 Apr 20; 44(4):322-334. PubMed ID: 35437240
    [Abstract] [Full Text] [Related]

  • 9. Epidermal growth factor-like domain-containing protein 7 (EGFL7) enhances EGF receptor-AKT signaling, epithelial-mesenchymal transition, and metastasis of gastric cancer cells.
    Luo BH, Xiong F, Wang JP, Li JH, Zhong M, Liu QL, Luo GQ, Yang XJ, Xiao N, Xie B, Xiao H, Liu RJ, Dong CS, Wang KS, Wen JF.
    PLoS One; 2014 Apr 20; 9(6):e99922. PubMed ID: 24945379
    [Abstract] [Full Text] [Related]

  • 10. Low expression of PDK1 inhibits renal cell carcinoma cell proliferation, migration, invasion and epithelial mesenchymal transition through inhibition of the PI3K-PDK1-Akt pathway.
    Zhou WM, Wu GL, Huang J, Li JG, Hao C, He QM, Chen XD, Wang GX, Tu XH.
    Cell Signal; 2019 Apr 20; 56():1-14. PubMed ID: 30465826
    [Abstract] [Full Text] [Related]

  • 11. Kinesin family member 18B: A contributor and facilitator in the proliferation and metastasis of cutaneous melanoma.
    Yan H, Zhu C, Zhang L.
    J Biochem Mol Toxicol; 2019 Dec 20; 33(12):e22409. PubMed ID: 31617652
    [Abstract] [Full Text] [Related]

  • 12. miR-128 targets the CC chemokine ligand 18 gene (CCL18) in cutaneous malignant melanoma progression.
    Song H, Tao Y, Ni N, Zhou X, Xiong J, Zeng X, Xu X, Qi J, Sun J.
    J Dermatol Sci; 2018 Sep 20; 91(3):317-324. PubMed ID: 30025750
    [Abstract] [Full Text] [Related]

  • 13. CHIP functions as an oncogene by promoting colorectal cancer metastasis via activation of MAPK and AKT signaling and suppression of E-cadherin.
    Xu J, Zhou J, Dai H, Liu F, Li W, Wang W, Guo F.
    J Transl Med; 2018 Jun 19; 16(1):169. PubMed ID: 29921293
    [Abstract] [Full Text] [Related]

  • 14. AKR1C3, a crucial androgenic enzyme in prostate cancer, promotes epithelial-mesenchymal transition and metastasis through activating ERK signaling.
    Wang B, Gu Y, Hui K, Huang J, Xu S, Wu S, Li L, Fan J, Wang X, Hsieh JT, He D, Wu K.
    Urol Oncol; 2018 Oct 19; 36(10):472.e11-472.e20. PubMed ID: 30139661
    [Abstract] [Full Text] [Related]

  • 15. Overexpression of microRNA-190 inhibits migration, invasion, epithelial-mesenchymal transition, and angiogenesis through suppression of protein kinase B-extracellular signal-regulated kinase signaling pathway via binding to stanniocalicin 2 in breast cancer.
    Sun G, Liu M, Han H.
    J Cell Physiol; 2019 Aug 19; 234(10):17824-17838. PubMed ID: 30993707
    [Abstract] [Full Text] [Related]

  • 16. ERas regulates cell proliferation and epithelial-mesenchymal transition by affecting Erk/Akt signaling pathway in pancreatic cancer.
    Liu Y, Qin P, Wu R, Du L, Li F.
    Hum Cell; 2020 Oct 19; 33(4):1186-1196. PubMed ID: 32700262
    [Abstract] [Full Text] [Related]

  • 17. Crocin Combined with Cisplatin Regulates Proliferation, Apoptosis, and EMT of Gastric Cancer Cells via the FGFR3/MAPK/ERK Pathway In vitro and In vivo.
    Li Y, Guo QJ, Chen R, Zhao L, Cui X, Deng Y, Luo YS.
    Curr Cancer Drug Targets; 2024 Oct 19; 24(8):835-845. PubMed ID: 37718528
    [Abstract] [Full Text] [Related]

  • 18. Knockdown of lncRNA GHET1 inhibits osteosarcoma cells proliferation, invasion, migration and EMT in vitro and in vivo.
    Yang W, Shan Z, Zhou X, Peng L, Zhi C, Chai J, Liu H, Yang J, Zhang Z.
    Cancer Biomark; 2018 Oct 19; 23(4):589-601. PubMed ID: 30475755
    [Abstract] [Full Text] [Related]

  • 19. MicroRNA-7 inhibits tumor metastasis and reverses epithelial-mesenchymal transition through AKT/ERK1/2 inactivation by targeting EGFR in epithelial ovarian cancer.
    Zhou X, Hu Y, Dai L, Wang Y, Zhou J, Wang W, Di W, Qiu L.
    PLoS One; 2014 Oct 19; 9(5):e96718. PubMed ID: 24816687
    [Abstract] [Full Text] [Related]

  • 20. LRIG1 acts as a critical regulator of melanoma cell invasion, migration, and vasculogenic mimicry upon hypoxia by regulating EGFR/ERK-triggered epithelial-mesenchymal transition.
    Li W, Zhou Y.
    Biosci Rep; 2019 Jan 31; 39(1):. PubMed ID: 30487162
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 41.